We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Urology

Journal Scan / Research · July 31, 2013

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

The New England Journal of Medicine

 

Additional Info

The New England Journal of Medicine
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
N. Engl. J. Med 2013 Jul 01;369(3)213-223, C Parker, S Nilsson, D Heinrich, SI Helle, JM O'Sullivan, SD Fosså, A Chodacki, P Wiechno, J Logue, M Seke, A Widmark, DC Johannessen, P Hoskin, D Bottomley, ND James, A Solberg, I Syndikus, J Kliment, S Wedel, S Boehmer, M Dall'Oglio, L Franzén, R Coleman, NJ Vogelzang, CG O'Bryan-Tear, K Staudacher, J Garcia-Vargas, M Shan, ØS Bruland, O Sartor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading